Stryker Inzone Detachment System Recalled Over Battery Drain: Health Canada

Health Canada has posted a Type II health product recall for the Inzone® Detachment System, a neurology medical device made by Stryker Neurovascular. The recall date is listed as September 11, 2026, and the public notice went live on September 24, 2026 under identification number RA-82677. The issue is classified as a medical device performance problem: some units may experience premature battery drain.

The notice is directed at the healthcare audience, not at general consumers. It matters most to hospitals, clinics and clinicians who stock or use the device.

Products Affected by This Recall

The recall covers one product, the Inzone® Detachment System, sold under the Stryker Neurovascular brand. Health Canada lists a single model or catalogue number for it.

• Product: Inzone® Detachment System
• Model or catalogue number: M00345100950
• Lot or serial numbers: More than 10 numbers are involved, and the notice directs readers to contact the manufacturer for the full list
• Brand: Stryker Neurovascular
• Recall class: Type II
• Recall date: 2026-09-11
• Identification number: RA-82677

The notice does not give a unit count, so the number of devices affected in Canada is not stated.

What Triggered the Recall

According to the Health Canada notice, Stryker has observed that some devices may experience premature battery drain. The notice does not explain the cause of the drain or say how many devices showed the problem.

When the battery drains early, the notice says the device may behave in one of three ways:

• It may not power on.
• It may power on with faint audible and visual indicators.
• It may be unable to detach a coil as intended.

The last item is the one most likely to matter in a clinical setting, because the device is meant to detach a coil and may not do so if the battery is depleted. The notice does not describe any patient consequences, and it does not list reported injuries or incidents.

Who Should Be Concerned

The audience listed on the notice is healthcare. Any facility or clinician holding an Inzone® Detachment System, model M00345100950, is the intended reader.

The notice names Stryker Neurovascular, based at 47900 Bayside Parkway, Fremont, California, United States, as the company responsible. The recall was published by Health Canada, and the alert is filed under health products, medical devices and neurology.

Because the lot and serial numbers run to more than 10 entries, the notice does not print them. A facility cannot tell from the public page alone which of its units fall within the recall. That is why the manufacturer is the designated point of contact.

How to Respond to This Recall

Health Canada’s guidance is short. Its ‘What to do’ section says to contact the manufacturer if you require additional information. Based on that, healthcare providers may want to take these steps:

• Check inventory for the Inzone® Detachment System, model M00345100950.
• Contact Stryker Neurovascular to obtain the full list of affected lot or serial numbers.
• Compare the manufacturer’s list with the units on hand.
• Ask the manufacturer for any further instructions on handling affected devices.

The notice does not describe a refund, replacement or return process. It also does not list a phone number or email address for Stryker. Anyone who needs those details should look them up directly through the manufacturer.

Anyone with a health or safety concern about a product can report it to Health Canada through the link on its recall page. The page also lets readers subscribe to email updates on new and revised recalls and safety alerts.

What the Agency Said

Health Canada published the recall as a health product recall in the medical devices category, with the issue listed as ‘Medical devices – Performance.’ Its stated summary of the problem reads as follows in substance: the manufacturer has seen premature battery drain in some devices, which can lead to the device not powering on, powering on with faint indicators, or being unable to detach a coil as intended.

The agency assigned the recall a Type II classification. The notice was first published and last updated on September 24, 2026. Because the page was published only recently, more details could follow, and readers should check the official Health Canada listing for changes.

Quick Takeaways

• Health Canada recall RA-82677 covers the Inzone® Detachment System from Stryker Neurovascular.
• The problem is premature battery drain that can stop the device from powering on or detaching a coil.
• The recall is Type II and aimed at healthcare audiences.
• More than 10 lot or serial numbers apply, and they must be obtained from the manufacturer.